ADIPOQ and breast carcinoma: In a meta-analysis published in 2018 by Li Gu et al., the analysis of thirty-one studies investigating the role of adiponectin levels in breast cancer risk suggested a significant decrease in serum adiponectin in breast cancer patients [59].